A Study to Investigate Apatinib Combined Capecitabine on Adjuvant Therapy of Biliary Carcinoma
Clinical trial NCT03609489 · UNKNOWN
Trial details
- NCT number
- NCT03609489
- Sponsor
- First Affiliated Hospital of Guangxi Medical University
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-09-10
- Primary completion
- 2021-06-10
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.